Product development plan for new vaccine technologies

被引：9

作者：

Ellis, RW ^{[1
]}

机构：

[1] Biochem Pharma, Northborough, MA 01532 USA

来源：

关键词：

D O I：

10.1016/S0264-410X(00)00352-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1559 / 1566

页数：8

共 8 条

[1]

Center for Biologics Evaluation and Research, 1997, GUID IND EV COMB VAC

[2]

*CTR BIOL EV RES, 1996, POINTS CONS PLASM DN

[3]

Ellis Ronald W., 1997, V39, P393

[4]

ELLIS RW, 1999, VACCINES, V3, P881

[5]

GOLDENTHAL KL, 1995, ANN NY ACAD SCI, V754, pR11, DOI 10.1111/j.1749-6632.1995.tb44430.x

[6] Current options for vaccine delivery systems by mucosal routes [J].

Mestecky, J ;

Moldoveanu, Z ;

Michalek, SM ;

Morrow, CD ;

Compans, RW ;

Schafer, DP ;

Russell, MW .

[7] Advances in vaccine adjuvants [J].

Singh, M ;

O'Hagan, D .

[8] Chances and risks of developing vaccines [J].

Struck, MM .